Submit Deal

Amit Sinha

Managing Director and Head of Biotechnology at GOLDMAN SACHS ALTERNATIVES

Investor

Deal Bio

Total Deals4

Valued Deals4

Total Value£ 6.12 B

Avg. Deal Size£ 1.53 B

Market Context

Sort

Target: AVEXIS INC

Bidder: NOVARTIS AG

12 Service Providers

60 Dealmakers

£ 5.28 B

Value

Target: THERACHON HOLDING AG

Bidder: PFIZER INC

9 Service Providers

48 Dealmakers

£ 645 M

Value

Target: MOMA THERAPEUTICS

Bidder: ROCK SPRINGS CAPITAL

15 Service Providers

14 Dealmakers

£ 121 M

Value

Target: AJAX THERAPEUTICS

Bidder: GOLDMAN SACHS ALTERNATIVES

5 Service Providers

6 Dealmakers

£ 75 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy